CBIO

NASDAQStock

Crescent Biopharma, Inc.

$11.27-0.29 (-2.55%)

52-Week Range

$8.94

$18.00

Key Stats

Market Cap

310.4M

P/E Ratio

—

Dividend Yield

—

Beta

1.30

Volume

84.5K

Avg Volume

141.2K

Performance

+29.31%

-12.49%

-7.52%

YTD

+4.33%

-26.81%

+285.33%

-87.37%

Price Chart

ETF Exposure

CBIO is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	3,989	$46K	$2.36B	0.25%
VXF	Vanguard Extended Market ETF	0.00%	81,936	$786K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	20	$260	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	715	$9K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$44	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	407,246	$3.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,142	$28K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	184	$2K	$1.29B	0.17%

About CBIO ETF Exposure

Crescent Biopharma, Inc. (CBIO) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 310.4M, CBIO is a widely held institutional stock. The stock currently trades at $11.27. Investors can gain exposure to CBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CBIO, sorted by portfolio weight.